1. Academic Validation
  2. Inhibition of phospholipase Cgamma1 and cancer cell proliferation by lignans and flavans from Machilus thunbergii

Inhibition of phospholipase Cgamma1 and cancer cell proliferation by lignans and flavans from Machilus thunbergii

  • Arch Pharm Res. 2004 Oct;27(10):1043-7. doi: 10.1007/BF02975429.
Ji Suk Lee 1 Jinwoong Kim Young Uck Yu Young Choong Kim
Affiliations

Affiliation

  • 1 Research group of Pain and Neuroscience, East-West Medical Research Institute, Kyung Hee University, Seoul 130-701, Korea.
Abstract

Thirteen compounds were isolated from the CH2Cl2 fraction of Machilus thunbergii as Phospholipase Cgamma1 (PLCgamma1) inhibitors. These compounds were identified as nine Lignans, two neolignans, and two flavans by spectroscopic analysis. Of these, 5,7-di-O-methyl-3',4'-methylenated (-)-epicatechin (12) and 5,7,3'-tri-O-methyl (-)-epicatechin (13) have not been reported previously in this plant. In addition, seven compounds, machilin A (1), (-)-sesamin (3), machilin G (5), (+)-galbacin (9), licarin A (10), (-)-acuminatin (11) and compound 12 showed dose-dependent potent inhibitory activities against PLCgamma1 in vitro with IC50 values ranging from 8.8 to 26.0 microM. These Lignans, neolignans, and flavans are presented as a new class of PLCgamma1 inhibitors. The brief study of the structure activity relationship of these compounds suggested that the benzene ring with the methylene dioxy group is responsible for the expression of inhibitory activities against PLCgamma1. Moreover, it is suggested that inhibition of PLCgamma1 may be an important mechanism for an antiproliferative effect on the human Cancer cells. Therefore, these inhibitors may be utilized as Cancer chemotherapeutic and chemopreventive agents.

Figures
Products